We’re thrilled to announce four new members of the ASAPbio Board of Directors: Gautam Dey, Carole Lee, Kleber Neves and Ludo Waltman. These appointments allow the Board to incorporate new perspectives from researchers in a wide range of disciplines including meta-research and also broaden the geographical representation in our Board.
Gautam is a Group Leader studying the evolution and organization of the nucleus at the European Molecular Biology Laboratory in Heidelberg (Germany). Gautam has been a member of the ASAPbio Community for several years, was a 2020 ASAPbio Fellow and contributed to the development of the FAST principles for preprint feedback. Gautam is also a founding member of the preLights community and a member of the Review Commons Advisory Board. Gautam is keen to see further reform in how science is communicated, saying “ASAPbio has had a transformative impact on the dissemination of research output in the life sciences, helping science move forward quicker, better and more transparently across the globe, strengthening the participation of early career researchers in the scientific ecosystem, and lowering traditional barriers between academia and the broader public. Much work remains to be done, amidst urgent global challenges ranging from pandemics to climate change”.
Carole is Associate Professor at the University of Washington, Seattle (US). Carole studies the production, communication, and evaluation of knowledge, and has worked on projects looking to increase transparency in journal review processes and facilitate the communication of open science elements. Carole is a member of the Advisory Board for the Transparency and Openness Promotion (TOP) Guidelines. For Carole, “as preprints open up and speed up scientific communication, it’s critical to contextualize their credibility – and to do so in ways that support researchers across different career stages, social groups, and geographic locations. ASAPbio’s efforts to create new cultures and mechanisms for preprint review are pathbreaking and essential. I’m thrilled to join the Board as ASAPbio continues to innovate around using preprints to advance knowledge, support scientists and build community.”
Kleber is science manager at the Serrapilheira Institute in Brazil. Prior to this role Kleber was a researcher working in neuroscience and meta-research. Since 2018, Kleber has been involved with the Brazilian Reproducibility Initiative, a project seeking to reproduce published experiments to estimate the reproducibility of Brazilian biomedical science. Kleber has a broad interest in open science and in ensuring this develops equitably, noting “I look forward to contributing to an organization whose work I’ve long admired from a distance. I hope I can help preprints and post-publication peer review grow to new heights, which I believe will make science better.”
Ludo is professor of Quantitative Science Studies and deputy director at the Centre for Science and Technology Studies at Leiden University (The Netherlands) and associate director of the Research on Research Institute. Ludo works on the development of new infrastructures and tools to support research assessment and scholarly communication. Ludo is co-organizer of the Publish Your Reviews initiative and coordinator of the Initiative for Open Abstracts (I4OA). Ludo sees opportunities ahead to transform scholarly communication: “There’s an urgent need for major innovations in the scholarly communication system and ASAPbio has shown to be highly successful in promoting such innovations. Ongoing developments around new publishing models, open science infrastructures, and reforms in research assessment are reinforcing each other, offering exciting opportunities for much-needed changes in scientific publishing practices. More than ever ASAPbio is uniquely positioned to work toward a more efficient, more open, and more equitable scholarly communication system.”
The perspectives and experience of these four new members strengthen the areas of expertise in our Board, and we look forward to working with them in ASAPbio’s ongoing and future initiatives!